Som230


Indications and Reactions:

Role Indications Reactions
Primary
Pancreatic Carcinoma 40.2%
Diabetes Mellitus 8.0%
Hypertension 7.1%
Pancreatic Neuroendocrine Tumour 6.7%
Pituitary-dependent Cushing's Syndrome 6.7%
Acromegaly 5.8%
Neuroendocrine Tumour 4.5%
Cushing's Syndrome 2.2%
Hepatocellular Carcinoma 2.2%
Hyperglycaemia 2.2%
Hypothyroidism 1.8%
Nelson's Syndrome 1.8%
Osteoporosis 1.8%
Prophylaxis 1.8%
Contusion 1.3%
Gastrooesophageal Reflux Disease 1.3%
Myasthenia Gravis 1.3%
Prostate Cancer Metastatic 1.3%
Analgesic Therapy 0.9%
Anxiety 0.9%
Hyperglycaemia 45.5%
Vomiting 10.7%
Nausea 6.3%
Cholecystitis Acute 3.6%
Diabetes Mellitus 3.6%
Ascites 2.7%
Hypoglycaemia 2.7%
Syncope 2.7%
Wound Infection 2.7%
Hypersensitivity 1.8%
Ileus 1.8%
Impaired Gastric Emptying 1.8%
Intra-abdominal Haemorrhage 1.8%
Pancreatic Leak 1.8%
Post Procedural Haemorrhage 1.8%
Pulmonary Embolism 1.8%
Pyrexia 1.8%
Sepsis 1.8%
Urinary Tract Infection 1.8%
Vision Blurred 1.8%
Secondary
Pancreatic Neuroendocrine Tumour 13.7%
Hypertension 9.2%
Neuroendocrine Tumour 9.2%
Gastrointestinal Carcinoma 7.8%
Pain 7.2%
Metastases To Bone 6.5%
Diabetes Mellitus 5.9%
Pituitary-dependent Cushing's Syndrome 5.9%
Osteoporosis 5.2%
Hypothyroidism 3.3%
Pulmonary Embolism 3.3%
Bronchitis 2.6%
Gastrooesophageal Reflux Disease 2.6%
Hypogonadism 2.6%
Metastatic Carcinoid Tumour 2.6%
Nelson's Syndrome 2.6%
Neoplasm Malignant 2.6%
Small Intestine Carcinoma Metastatic 2.6%
Thyroid Cancer 2.6%
Hypercholesterolaemia 2.0%
Jaundice 11.6%
Syncope 9.3%
Faeces Discoloured 7.0%
Injection Site Reaction 7.0%
Ketoacidosis 7.0%
Vomiting 7.0%
Arthritis Bacterial 4.7%
Diabetes Mellitus 4.7%
Diabetic Ketoacidosis 4.7%
Gingival Pain 4.7%
Hyperglycaemia 4.7%
Nausea 4.7%
Vertigo Positional 4.7%
Xanthoma 4.7%
Anaemia 2.3%
Cholecystitis Acute 2.3%
Disturbance In Attention 2.3%
Fall 2.3%
Febrile Neutropenia 2.3%
Gamma-glutamyltransferase Increased 2.3%

Drug Data